THC Therapeutics, Inc. reported earnings results for the third quarter and nine months ended April 30, 2022. For the third quarter, the company reported net loss was USD 0.632278 million compared to USD 0.35078 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.
For the nine months, net loss was USD 1.87 million compared to USD 0.800655 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.03 a year ago.